Outside stenting of the vein graft decreases VEGF-A expression and induces significant down-regulation of VEGFR-1 in the intimal and medial layers after the re-endothelialization period

Medical Science Monitor

Volumn 16, Issue 3, 2010, Pages

  Krejca, Michał ^a   Plewka, Andrzej ^a   Szmagala, Przemysław ^a   Plewka, Danuta ^a   Nowaczyk, Grazyna ^a   Skarysz, Janusz ^a   Białek, Krzysztof ^a   Guc, Michał ^a   Bochenek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Coronary heart disease; Hybrid vein graft; Intimal hyperplasia; VEGF A VEGF receptor 1

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM; HISTOGENESIS; INTIMA; MALE; NONHUMAN; PROTEIN EXPRESSION; RADIAL VEIN; REENDOTHELIALIZATION; REGENERATION; SHEEP; STENT; TUNICA MEDIA; VEIN; VEIN GRAFT;

ANIMALS; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; MALE; SHEEP; STENTS; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VEINS;

EID: 77649265236     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lytle BW, Loop FD, Thurer RL: Isolated left anterior descending coronary atheriosclerosis: long-term comparison of internal mammary artery and venous autografts. Circulation, 1980; 61: 869-74
2. Favarolo RG: Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. J Thorac Cardiovasc Surg, 1969; 58: 178-85
3. Dashwood MR, Anand R, Loesch A et al: Hypothesis: a potential role for the vasa vasorum in maintenance of vein graft patency. Angiology, 2004; 55: 385-95
4. Motwani JG, Topol EJ: Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention. Circulation, 1998; 97: 916-31
5. Allaire E, Clowes AW: Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg, 1997; 63: 582-91
6. Krejca M, Skarysz J, Szmagała P et al: A new outside stent - does it prevent vein graft intimal proliferation? Eur J Cardiothorac Surg, 2002; 22: 898-903
7. Grondin CM, Campeau L, Lesperance J et al: Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation, 1984; 70(Suppl.1): 208-12
8. Echave V, Koornick AR, Haimov M et al: Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoralpopliteal bypass. Surgery, 1979; 86: 791-98
9. Westerband A, Crouse D, Richter LC et al: Vein adaptation to arterialization in an experimental model. J Vasc Surg, 2001; 33: 561-69
10. Luo Z, Asahara T, Tsurumi Y et al: Reduction of vein graft intimal hyperplasia and preservation of endothelium - dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg, 1998; 27: 167-71
11. Stary HC, Blankenhorn DH, Bleakley Chandler A et al: A definition of the intima of human arteries and its atherosclerosis-prone regions: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation, 1992; 85: 391-405
12. Clinton SK, Dinarello CA, Cannon JG et al: Induction in vitro of interleukin I gene expression in rabbit aortic tissue. Circulation, 1988; 78: 65-68
13. Geistefer AA, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res, 1988; 62: 749-52
14. Klagsbrum M, Edelman ER: Biological and biochemical properties of fibroblast growth factor: implications for the pathogenesis of atherosclerosis. Atherosclerosis, 1989; 9: 269-77
15. Raines EW, Dower SK, Ross R: Interleukin-I mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science, 1989; 243: 393-96
16. Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA, 1991; 88: 3739-43
17. Olson NE, Chao S, Lindner V et al: Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol, 1992; 140: 1017-23
18. Koyama N, Hart CE, Clowes AW: Different functions of the platelet-derived growth factor -α and -β receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res, 1994; 75: 682-91
19. Jawien A, Bowen-Pope DF, Lindner V et al: Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest, 1992; 89: 507-11
20. Lindner V, Giachelli CM, Schwartz SM et al: A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res, 1995; 76: 951-7
21. Majesky MW, Lindner V, Twardzik DR et al: Production of transforming growth factor β-1 during repair of arterial injury. J Clin Invest, 1991; 88: 904-10
22. Neufeld G, Cohen T, Gengrinovitch S et al: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J, 1999; 13: 9-22
23. Zachary I, Gliki G: Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res, 2001; 49: 568-81
24. Parenti A, Brogelli L, Filippi S et al: Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1. Cardiovasc Res, 2002; 55: 201-12
25. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med, 1995; 1: 27-31
26. Isner JM, Losordo DW: Therapeutic angiogenesis for heart failure. Nat Med, 1999; 5: 491-92
27. Zachary I, Mathur A, Yla-Herttuala S et al: Vascular protection: a novel, non-angiogenic cardiovascular role for vascular endothelial growth factor. Arterisclerosis Thromb Vasc Biol, 2000; 20: 1512-20
28. Garg UC, Hassid A: Nitric oxide - generating vasodilatators and 8-bromo-cyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest, 1989; 83: 1774-77
29. Nakahashi T, Fukuo K, Inoue T et al: Endothelin-1 enhances nitric oxide-induced cytotoxicity in vascular smooth muscle. Hypertension, 1995; 25: 744-47
30. Angelini GD, Christie MI, Bryan AJ et al: Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann Thorac Surg, 1989; 48: 417-20
31. Ishida A, Murray J, Saito Y et al: Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol, 2001; 188: 359-68
32. Couper LL, Bryant SR, Eldrup-Jorgensen J et al: Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res, 1997; 81: 932-39
33. Katoh O, Tauchi H, Kawaishi K et al: Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoetic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res, 1995; 55: 5687-92
34. Takahashi T, Shirasawa T, Miyake K et al: Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: FLT-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun, 1995; 209: 218-26
35. Stooker W, Niessen HW, Baidoshvili A et al: Perivenous support reduced early changes in human vein grafts: studies in whole blood perfused human vein segments. J Thorac and Cardiovasc Surg, 2001; 121: 290-97
36. Angelini GD, Izzat MB, Bryan AJ et al: External stenting reduces early medial and neointimal thickening in a pig model of arteriovenous bypass grafting. J Thorac Cardiovasc Surg, 1996; 112: 79-84
37. Zurbruegg HR, Wied M, Angelini GD et al: Reduction of intimal and medial thickening in sheathed vein grafts. Ann Thorac Surg, 1999; 68: 79-83
38. Stadnicki A, Mazurek U, Gonciarz M et al: Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease. Dig Dis Sci, 2003; 48: 615-23
39. Davies MG, Hagen PO: Structural and functional consequences of bypass grafting with autologous vein. Cryobiology, 1994; 31: 63-70
40. Davies MG, Kim JH, Dalen H et al: Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery, 1994; 116: 557-68
41. Zhao Q, Egashira K, Hiasa K et al: Essential role of vascular endothelial growth factor and flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vascular Biol, 2004; 24: 2284-89
42. Logerfo FW, Quist WC, Cantelmo NL et al: Integrity of vein grafts as a function of initial intimal and medial preservation. Circulation, 1983; 68: 117-21
43. De Ruiter MC, Pocimann RE, van Munsteren JC: Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res, 1997; 80: 444-49
44. Woodside KJ, Naoum JJ, Torry RJ et al: Altered expression of vascular endothelial growth factor and its receptors in normal saphenous + vein arterialized and stenotic vein graft. Am Surg, 2003; 186: 561-68.